Exploring Time Off Treatment with a BCL-2 Inhibitor Presentation – September 4th
You’re invited to attend a clinical presentation about the efficacy and safety of VENCLEXTA regimens in the treatment of CLL
Exploring Time Off Treatment with a BCL-2 Inhibitor: A REview of VENCLEXTA-Based Regimens for Patients with CLL/SLL
Bita Fakhri, MD, Assistant Professor of Medicine, Division of Hematology, Stanford University
DATE/TIME: Wednesday, September 04, 2024 | Program Time: 6:30 PM PT
LOCATION: Fleming’s Prime Steakhouse, 180 El Camino Real, Palo Alto, 94304
RSVP: By Monday, August 26, 2024 to Julie Caradonna, 8206003271, julie.caradonna@abbvie.com
RSVP Online: rsvp.abbviespeakerprograms.com/id/201064